Table Info

Table 1.

Adsorption parameters and results for adsorption isotherm models

Model	Parameter	4°C	25°C	37°C
Langmuir	q_m (mg mg^–1)	0.0043 ± 0.0004 (R² = 0.7863)	0.0045 ± 0.0002 (R² = 0.9432)	0.0236 ± 0.0169 (R² = 0.9617)
Langmuir	K_a (L mmol^–1)	0.0314 ± 0.0126	0.1013 ± 0.0115	0.8702 ± 0.7818
Freundlich	K_F (L g^–1)	0.0064 ± 0.0010	0.0047 ± 0.0002	0.0195 ± 0.0036
Freundlich	n	0.3652 ± 0.0824	0.3615 ± 0.0258	0.9347 ± 0.1200
Dubinin-Radushkevich	q_DR (μmol g^–1)	8,882 ± 801.8	8,236 ± 210.0	12,613 ± 2,553.0
Dubinin-Radushkevich	K_DR (mol² k^–1J^–2)	0.0113 ± 0.0025	0.0184 ± 0.0011	0.0256 ± 0.0089
Temkin	K_T (mL mg^–1)	1,782 ± 253.6	1,555 ± 79.4	2,400 ± 400.1
Temkin	b (J mol^–1)	268.9 ± 123.5	178.5 ± 31.0	112.0 ± 44.4

q_m: maximum adsorption capacity; K_a: Langmuir constant; K_F: adsorption capacity constant; n: heterogeneity factor; q_DR: Dubinin-Radushkevich maximum adsorption capacity; K_DR: Dubinin-Radushkevich isotherm constant; K_T: equilibrium binding constant; b: Temkin constant

Declarations

Acknowledgments

The authors express their sincere gratitude to Dr. Gisela S. Alvarez for generously providing the 3T3 mouse fibroblast cells, to Dr. Guillermo J. Copello for his invaluable assistance with the interpretation of isotherms and kinetic data, and to Dr. Andrea M. Mebert and Dr. Rodrigo N. Nuñez for their thoughtful revisions and contributions to the final version of the manuscript.

Author contributions

JMG: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Software, Validation, Visualization, Writing—original draft, Writing—review & editing. MVO: Formal analysis, Investigation, Methodology, Software, Writing—original draft. AI, DHF, and CMMQ: Investigation, Writing—original draft, Writing—review & editing. MFD: Resources. HP: Data curation, Formal analysis, Investigation, Methodology, Resources, Software, Validation. MVT: Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing—original draft, Writing—review & editing. All authors read and approved the submitted version.

Conflicts of interest

The authors declare that they have no conflicts of interest.

Ethical approval

Not applicable.

Consent to participate

Not applicable.

Consent to publication

Not applicable.

Availability of data and materials

The raw data supporting the conclusions of this manuscript will be made available by the authors, without undue reservation, to any qualified researcher.

Funding

CMMQ is grateful for her doctoral fellowship granted by Universidad de Buenos Aires [RESCD-2024-639-E-UBA-DCT]. This study received grants from the Universidad de Buenos Aires [UBACYT 20020220400378BA, UBACYT 20020190200009BA] and from Agencia Nacional de Investigaciones Científicas y Técnicas [PICT 2018-4154] (to MVT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Copyright

Publisher’s note

Open Exploration maintains a neutral stance on jurisdictional claims in published institutional affiliations and maps. All opinions expressed in this article are the personal views of the author(s) and do not represent the stance of the editorial team or the publisher.

References

Ezike TC, Okpala US, Onoja UL, Nwike CP, Ezeako EC, Okpara OJ, et al. Advances in drug delivery systems, challenges and future directions. Heliyon. 2023;9:e17488. [DOI] [PubMed] [PMC]

Liu K, Mo Q, Ding Z, Lai S, Ren J, Yu Q. Nano theranostics involved in bladder cancer treatment. Explor Drug Sci. 2023;1:81–106. [DOI]

Xu B, Li S, Shi R, Liu H. Multifunctional mesoporous silica nanoparticles for biomedical applications. Signal Transduct Target Ther. 2023;8:435. [DOI] [PubMed] [PMC]

Djayanti K, Maharjan P, Cho KH, Jeong S, Kim MS, Shin MC, et al. Mesoporous Silica Nanoparticles as a Potential Nanoplatform: Therapeutic Applications and Considerations. Int J Mol Sci. 2023;24:6349. [DOI] [PubMed] [PMC]

Salt AN, Hartsock JJ, Piu F, Hou J. Dexamethasone and Dexamethasone Phosphate Entry into Perilymph Compared for Middle Ear Applications in Guinea Pigs. Audiol Neurootol. 2018;23:245–57. [DOI] [PubMed] [PMC]

Noreen S, Maqbool I, Madni A. Dexamethasone: Therapeutic potential, risks, and future projection during COVID-19 pandemic. Eur J Pharmacol. 2021;894:173854. [DOI] [PubMed] [PMC]

Kim SJ, Choi Y, Min KT, Hong S. Dexamethasone-Loaded Radially Mesoporous Silica Nanoparticles for Sustained Anti-Inflammatory Effects in Rheumatoid Arthritis. Pharmaceutics. 2022;14:985. [DOI] [PubMed] [PMC]

Manzano M, Colilla M, Vallet-Regí M. Drug delivery from ordered mesoporous matrices. Expert Opin Drug Deliv. 2009;6:1383–400. [DOI] [PubMed]

Tuttolomondo MV, Villanueva ME, Alvarez GS, Desimone MF, Díaz LE. Preparation of submicrometer monodispersed magnetic silica particles using a novel water in oil microemulsion: properties and application for enzyme immobilization. Biotechnol Lett. 2013;35:1571–7. [DOI] [PubMed]

10.

Mebert AM, Aimé C, Alvarez GS, Shi Y, Flor SA, Lucangioli SE, et al. Silica core-shell particles for the dual delivery of gentamicin and rifamycin antibiotics. J Mater Chem B. 2016;4:3135–44. [DOI] [PubMed]

11.

Kamarudin NHN, Jalil AA, Triwahyono S, Salleh NFM, Karim AH, Mukti RR, et al. Role of 3-aminopropyltriethoxysilane in the preparation of mesoporous silica nanoparticles for ibuprofen delivery: Effect on physicochemical properties. Microporous Mesoporous Mater. 2013;180:235–41. [DOI]

12.

Castillo RR, Lozano D, Vallet-Regí M. Mesoporous Silica Nanoparticles as Carriers for Therapeutic Biomolecules. Pharmaceutics. 2020;12:432. [DOI] [PubMed] [PMC]

13.

Hoang Thi TT, Cao VD, Nguyen TNQ, Hoang DT, Ngo VC, Nguyen DH. Functionalized mesoporous silica nanoparticles and biomedical applications. Mater Sci Eng C. 2019;99:631–56. [DOI] [PubMed]

14.

Kolimi P, Narala S, Youssef AAA, Nyavanandi D, Dudhipala N. A systemic review on development of mesoporous nanoparticles as a vehicle for transdermal drug delivery. Nanotheranostics. 2023;7:70–89. [DOI] [PubMed] [PMC]

15.

Lérida-Viso A, Estepa-Fernández A, García-Fernández A, Martí-Centelles V, Martínez-Máñez R. Biosafety of mesoporous silica nanoparticles; towards clinical translation. Adv Drug Deliv Rev. 2023;201:115049. [DOI] [PubMed]

16.

Mebert AM, Evelson PA, Desimone MF, Maysinger D. Human lung cell cytotoxicity of antibacterial-loaded silica nanoparticles. J Drug Delivery Sci Technol. 2024;92:105298. [DOI]

17.

Tuttolomondo MV, Galdopórpora JM, Trichet L, Voisin H, Coradin T, Desimone MF. Dye–collagen interactions. Mechanism, kinetic and thermodynamic analysis. RSC Adv. 2015;5:57395–405. [DOI]

18.

Ho YS, McKay G. Pseudo-second order model for sorption processes. Process Biochem. 1999;34:451–65. [DOI]

19.

Langmuir I. THE ADSORPTION OF GASES ON PLANE SURFACES OF GLASS, MICA AND PLATINUM. J Am Chem Soc. 1918;40:1361–403. [DOI]

20.

Freundlich H. Über die Adsorption in Lösungen. Z Phys Chem. 1907;57U:385–470. German. [DOI]

21.

Hu Q, Zhang Z. Application of Dubinin–Radushkevich isotherm model at the solid/solution interface: A theoretical analysis. J Mol Liq. 2019;277:646–8. [DOI]

22.

Dada AO, Lekan AP, Olatunya AM, Dada O. Langmuir, Freundlich, Temkin and Dubinin–Radushkevich Isotherms Studies of Equilibrium Sorption of Zn²⁺ Unto Phosphoric Acid Modified Rice Husk. IOSR J Appl Chem. 2012;3:38–45. [DOI]

23.

Askarizadeh M, Esfandiari N, Honarvar B, Sajadian SA, Azdarpour A. Kinetic Modeling to Explain the Release of Medicine from Drug Delivery Systems. CBEN. 2023;10:1006–49. [DOI]

24.

Wojcik-Pastuszka D, Krzak J, Macikowski B, Berkowski R, Osiński B, Musiał W. Evaluation of the Release Kinetics of a Pharmacologically Active Substance from Model Intra-Articular Implants Replacing the Cruciate Ligaments of the Knee. Materials (Basel). 2019;12:1202. [DOI] [PubMed] [PMC]

25.

Higuchi WI. Diffusional Models Useful in Biopharmaceutics: Drug Release Rate Processes. J Pharm Sci. 1967;56:315–24. [DOI]

26.

Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm. 1983;15:25–35. [DOI]

27.

Alvarez Echazú MI, Renou SJ, Alvarez GS, Desimone MF, Olmedo DG. Synthesis and Evaluation of a Chitosan–Silica-Based Bone Substitute for Tissue Engineering. Int J Mol Sci. 2022;23:13379. [DOI] [PubMed] [PMC]

28.

Galdopórpora JM, Ibar A, Tuttolomondo MV, Desimone MF. Dual-effect core–shell polyphenol coated silver nanoparticles for tissue engineering. Nano-Struct Nano-Objects. 2021;26:100716. [DOI]

29.

Kaasalainen M, Aseyev V, von Haartman E, Karaman DŞ, Mäkilä E, Tenhu H, et al. Size, Stability, and Porosity of Mesoporous Nanoparticles Characterized with Light Scattering. Nanoscale Res Lett. 2017;12:74. [DOI] [PubMed] [PMC]

30.

Shen SC, Ng WK, Chia L, Dong YC, Tan RBH. Sonochemical synthesis of (3-aminopropyl)triethoxysilane-modified monodispersed silica nanoparticles for protein immobilization. Mater Res Bull. 2011;46:1665–9. [DOI]

31.

Hiraoui M, Guendouz M, Lorrain N, Moadhen A, Haji L, Oueslati M. Spectroscopy studies of functionalized oxidized porous silicon surface for biosensing applications. Mater Chem Phys. 2011;128:151–6. [DOI]

32.

Salazar Camacho CA, Villalobos Peñalosa M. CHARACTERIZATION AND SURFACE REACTIVITY OF NATURAL AND SYNTHETIC MAGNETITES: II. ADSORPTION OF Pb(II) AND Zn(II). Rev Int Contam Ambient. 2017;33:165–76. [DOI]